Though identified before insulin, phlorizin was limited as a diabetes treatment because of its poor oral absorption and its effects to reduce intestinal glucose absorption that causes diarrhea through nonselective inhibition of SGLT1 which is prominently expressed in the gut lumen (5). The gene discussed is INS; the disease is diabetes mellitus.